Evaluation of Tuberculosis Treatment Response With Serial C-Reactive Protein Measurements

BACKGROUND: Novel biomarkers are needed to assess response to antituberculosis therapy in smear-negative patients. METHODS: To evaluate the utility of C-reactive protein (CRP) in monitoring response to antituberculosis therapy, we conducted a post hoc analysis on a cohort of adults with symptoms of...

Descripción completa

Detalles Bibliográficos
Autores principales: Wilson, Douglas, Moosa, Mahomed-Yunus S, Cohen, Ted, Cudahy, Patrick, Aldous, Collen, Maartens, Gary
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2018
Materias:
Major Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240901/
https://www.ncbi.nlm.nih.gov/pubmed/30474046
http://dx.doi.org/10.1093/ofid/ofy253

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6240901/
https://www.ncbi.nlm.nih.gov/pubmed/30474046
http://dx.doi.org/10.1093/ofid/ofy253

Ejemplares similares